SCHEMBL7069231

SCHEMBL7069231

O=C(O)C(Cc1ccccc1OCc1cnc2ccccc2c1)Sc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.39
PPARA Q07869 1/20 0.38
MGAM O43451 1/20 0.37
TPH1 P17752 1/20 0.37
PDE10A Q9Y233 1/20 0.37
SCN9A Q15858 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.36
RAB9A P51151 1/20 0.36
STAT3 P40763 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CFTR P13569 1/20 0.36
NOTUM Q6P988 1/20 0.36
CGAS Q8N884 1/20 0.36
PTGER1 P34995 1/20 0.36
PTGER4 P35408 1/20 0.36
PTGER3 P43115 1/20 0.36
PTGER2 P43116 1/20 0.36
PTGES O14684 1/20 0.36
ALOX5 P09917 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7070136 0.93 KMT2A (0.42) PPARGPPARAHTTSMN1; SMN2PTGER1
SCHEMBL7069255 0.87 MME (0.39) TPH1PDE10ASCN9ASIRT2RAB9A
SCHEMBL7604848 0.86 MGAM (0.43) MGAMTPH1PDE10ASCN9ASIRT2
SCHEMBL7066053 0.86 FFAR4 (0.38) TPH1PDE10ASCN9ASIRT2STAT3
SCHEMBL7069229 0.84 PPARG (0.52) PPARGPPARATPH1ALOX5
SCHEMBL7067687 0.84 MGAM (0.41) MGAMTPH1PDE10ASCN9ASIRT2
SCHEMBL7065979 0.83 MME (0.42) MGAMTPH1PDE10ASCN9ASIRT2
SCHEMBL7066080 0.82 SMN1; SMN2 (0.41) MGAMTPH1PDE10ASCN9ASIRT2
SCHEMBL7069510 0.82 TRPV1 (0.41) PPARGPPARAPDE10APTGESALOX5
SCHEMBL7068772 0.81 PDE10A (0.42) MGAMPDE10ASCN9ASIRT2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212100-A1 Quinoline derivatives and medicinal use thereof MITSUI CHEMICALS, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212100-A1 Quinoline derivatives and medicinal use thereof PPARG, PPARD, PPARA PPARG 1/4885PPARA 3/4885MGAM 4722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.